These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25075216)

  • 1. The Repurposing Drugs in Oncology (ReDO) Project.
    Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP; Vikas P
    Ecancermedicalscience; 2014; 8():442. PubMed ID: 25075216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ReDO_DB: the repurposing drugs in oncology database.
    Pantziarka P; Verbaanderd C; Sukhatme V; Rica Capistrano I; Crispino S; Gyawali B; Rooman I; Van Nuffel AM; Meheus L; Sukhatme VP; Bouche G
    Ecancermedicalscience; 2018; 12():886. PubMed ID: 30679953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing drugs in oncology: From candidate selection to clinical adoption.
    Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
    Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of drugs for triple negative breast cancer: an overview.
    Spini A; Donnini S; Pantziarka P; Crispino S; Ziche M
    Ecancermedicalscience; 2020; 14():1071. PubMed ID: 32728387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent.
    Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP
    Ecancermedicalscience; 2014; 8():443. PubMed ID: 25075217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.
    Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP
    Ecancermedicalscience; 2014; 8():485. PubMed ID: 25525463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.
    Pantziarka P; Bouche G; Sukhatme V; Meheus L; Rooman I; Sukhatme VP
    Ecancermedicalscience; 2016; 10():680. PubMed ID: 27899953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent.
    Pantziarka P; Sukhatme V; Bouche G; Meheus L; Sukhatme VP
    Ecancermedicalscience; 2016; 10():610. PubMed ID: 26823679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.
    Verbaanderd C; Maes H; Schaaf MB; Sukhatme VP; Pantziarka P; Sukhatme V; Agostinis P; Bouche G
    Ecancermedicalscience; 2017; 11():781. PubMed ID: 29225688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.
    Sukhatme V; Bouche G; Meheus L; Sukhatme VP; Pantziarka P
    Ecancermedicalscience; 2015; 9():568. PubMed ID: 26435741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.
    Pantziarka P; Sukhatme V; Bouche G; Meheus L; Sukhatme VP
    Ecancermedicalscience; 2015; 9():521. PubMed ID: 25932045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists.
    Revon-Rivière G; Banavali S; Heississen L; Gomez Garcia W; Abdolkarimi B; Vaithilingum M; Li CK; Leung PC; Malik P; Pasquier E; Epelman S; Chantada G; André N
    J Glob Oncol; 2019 Jul; 5():1-8. PubMed ID: 31260397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?
    Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP
    Future Oncol; 2015; 11(2):181-4. PubMed ID: 25591833
    [No Abstract]   [Full Text] [Related]  

  • 14. Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.
    Pantziarka P; Sukhatme V; Crispino S; Bouche G; Meheus L; Sukhatme VP
    Ecancermedicalscience; 2018; 12():824. PubMed ID: 29743944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Repurposing in Oncology: Current Evidence and Future Direction.
    Zhang Z; Ji J; Liu H
    Curr Med Chem; 2021; 28(11):2175-2194. PubMed ID: 33109032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead.
    Shah RR; Stonier PD
    J Clin Pharm Ther; 2019 Feb; 44(1):6-22. PubMed ID: 30218625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Drugs in Small Animal Oncology.
    Giuliano A; Horta RS; Vieira RAM; Hume KR; Dobson J
    Animals (Basel); 2022 Dec; 13(1):. PubMed ID: 36611747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.
    Hernandez JJ; Pryszlak M; Smith L; Yanchus C; Kurji N; Shahani VM; Molinski SV
    Front Oncol; 2017; 7():273. PubMed ID: 29184849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp.
    Hijazi MA; Gessner A; El-Najjar N
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.